Viewing Study NCT03025893

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:19 AM
Ignite Modification Date: 2026-01-06 @ 2:35 AM
Study NCT ID: NCT03025893
Status: UNKNOWN
Last Update Posted: 2021-04-19
First Post: 2017-01-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase II/III Study of High-dose, Intermittent Sunitinib in Patients With Recurrent Glioblastoma Multiforme
Sponsor: Amsterdam UMC, location VUmc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Brain Tumor View
None GBM View
None Glioblastoma Multiforme View
None Glioblastoma, Adult View
None Glioblastoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Sunitinib View
None Lomustine View
None High-dose View
None Intermittent View